Organogenesis

Organogenesis is a leading regenerative medicine company focused on empowering healing through the development, manufacturing, and sale of products for the advanced wound care and surgical and sports medicine markets. Founded in 1985, the company leverages innovation to address critical patient needs across various medical fields, aiming to improve patient outcomes and enhance the continuum of care with pioneering regenerative solutions.

Operating with an employee range of 500 - 1,000 individuals, Organogenesis maintains a significant operational footprint across 5 locations. The company's product portfolio centers on regenerative medicine, including advanced wound care solutions and biomaterials for surgical and sports medicine applications. This focus positions Organogenesis as a key player in the manufacturing sector, particularly within the medical devices and equipment industry. Learn about Organogenesis's global headquarters for detailed geographic information. Meet Organogenesis's team to understand the expertise driving their product development and market strategy.

With a reported revenue of $514.7M, Organogenesis demonstrates substantial market presence. The company has secured various funding rounds, including private equity and debt financing, totaling over $100 million, underscoring investor confidence in its growth trajectory. Its competitive landscape includes entities like MiMedx Group and LifeNet Health, highlighting the dynamic nature of the regenerative medicine and advanced wound care sectors. Explore financial highlights for a deeper dive into their fiscal performance and investment history.